GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (STU:Z45) » Definitions » Construction In Progress

Alvotech (STU:Z45) Construction In Progress : €0.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Construction In Progress?


Alvotech Construction In Progress Historical Data

The historical data trend for Alvotech's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Construction In Progress Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
- - - - -

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alvotech Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Alvotech (STU:Z45) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Alvotech (STU:Z45) Headlines

No Headlines